Singapore markets open in 2 hours 43 minutes

Astria Therapeutics, Inc. (ATXS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
9.35-0.15 (-1.58%)
At close: 04:00PM EDT
9.35 0.00 (0.00%)
After hours: 04:01PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close9.50
Open9.61
Bid9.32 x 200
Ask9.37 x 200
Day's range9.21 - 9.78
52-week range4.26 - 16.90
Volume797,047
Avg. volume1,043,662
Market cap513.438M
Beta (5Y monthly)0.71
PE ratio (TTM)N/A
EPS (TTM)-2.42
Earnings date09 May 2024 - 13 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est24.29
  • Business Wire

    Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    BOSTON, May 02, 2024--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, granted stock options to purchase 173,500 shares of Astria’s common stock on May 1, 2024 under Astria’s 2022 Inducement Stock Incentive Plan. The 2022 Inducement Stock Incentive Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee of Astria.

  • Business Wire

    Astria Therapeutics Appoints Sunil Agarwal to Its Board of Directors

    BOSTON, April 09, 2024--Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced the appointment of Sunil Agarwal, M.D., to its Board of Directors. Dr. Agarwal has more than 20 years of biotechnology research, development, and commercialization experience.

  • GuruFocus.com

    Chief Medical Officer Christopher Morabito Sells 10,000 Shares of Astria Therapeutics Inc (ATXS)

    Astria Therapeutics Inc (NASDAQ:ATXS), a biopharmaceutical company focused on the discovery, development, and commercialization of novel therapies to treat debilitating diseases, has reported an insider sale according to a recent SEC filing.